Sean Dodge is ranked #1139 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

BMO

Sean Dodge

Q: How accurate are Sean Dodge's stock ratings?

About 65% of Sean's ratings were profitable over a one-year hold, with an average return of +6.3% per rating, measured by 13Foresight from historical prices.

BMO Capital

Wall Street Analyst

★★★☆☆

#1139

on 13Foresight · ranked by our own returns

63%

Success Rate

+6.3%

Average Return

31 of 49 calls profitable · +1.0% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compared To ⓘ

S&P 500 (SPY)

📈 Across the calls we could measure, roughly 63% of Sean Dodge's ratings turned a profit when each position was held for 1 year — averaging +6.3% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

56 Buy 39 Hold 0 Sell

Sean's Stock Coverage 30 ratings · 2026-08-10

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return	vs S&P 500 ⓘ
PRVA Privia Health Group	Aug 07, 2026	BUY	Strong Buy +42.3% avg upside 26 analysts	$30.00 33.55% Upside	-0.4%	·
OMDA Omada Health, Inc.	Aug 06, 2026	BUY	Strong Buy +8.8% avg upside 12 analysts	$24.00 1.46% Upside	+27.9%	·
DOCS Doximity	Aug 06, 2026	HOLD	Buy +28.7% avg upside 28 analysts	$30.00 9.49% Upside	+36.0%	·
EVH Evolent Health	Aug 06, 2026	BUY	Strong Buy +143.9% avg upside 19 analysts	$6.00 51.98% Upside	+9.5%	·
LFST Lifestance Health Group	Aug 06, 2026	BUY	Strong Buy +3.4% avg upside 15 analysts	$13.00 19.86% Upside	+1.7%	·
SHC Sotera Health	Aug 06, 2026	BUY	Strong Buy +16.3% avg upside 13 analysts	$22.00 16.64% Upside	+0.3%	·
MDLN Medline	Aug 05, 2026	BUY	Strong Buy +37.8% avg upside 27 analysts	$47.00 33.42% Upside	-7.7%	·
ADUS Addus Homecare	Aug 04, 2026	HOLD	Strong Buy +7.1% avg upside 18 analysts	$115.00 3.90% Downside	+5.3%	·
CERT Certara	Aug 04, 2026	HOLD	Buy +61.0% avg upside 22 analysts	$8.00 2.44% Downside	+5.1%	·
BTSG BrightSpring Health Services, Inc.	Aug 03, 2026	BUY	Strong Buy +6.0% avg upside 20 analysts	$70.00 12.03% Upside	+11.7%	·
IQV IQVIA Holdings	Jul 29, 2026	BUY	Strong Buy +1.4% avg upside 39 analysts	$270.00 13.18% Upside	-2.2%	·
WAY Waystar Holding Corp.	Jul 29, 2026	BUY	Strong Buy +52.7% avg upside 30 analysts	$30.00 23.83% Upside	-7.6%	·
TDOC Teladoc	Jul 29, 2026	HOLD	Buy +306.2% avg upside 38 analysts	$7.00 1.91% Downside	-22.3%	·
MEDP Medpace Holdings	Jul 27, 2026	HOLD	Buy -18.0% avg upside 17 analysts	$600.00 1.64% Upside	+2.2%	·
HCSG Healthcare Services	Jul 22, 2026	HOLD	Buy +10.2% avg upside 12 analysts	$24.00 8.04% Upside	-6.4%	·
ICLR Icon	Jun 25, 2026	BUY	Strong Buy +14.1% avg upside 26 analysts	$187.00 13.75% Upside	+3.2%	·
PHR Phreesia	Jun 22, 2026	BUY	Strong Buy +36.8% avg upside 21 analysts	$14.00 11.91% Upside	+28.8%	·
VEEV Veeva Systems	Jun 03, 2026	HOLD	Buy +3.4% avg upside 37 analysts	$175.00 24.06% Downside	+31.1%	·
AVAH Aveanna Healthcare Holdings	May 15, 2026	BUY	Buy -1.0% avg upside 18 analysts	$10.00 5.43% Upside	+22.0%	·
HQY Healthequity	Apr 09, 2026	BUY	Strong Buy +8.5% avg upside 20 analysts	$105.00 0.45% Upside	+24.3%	·
GDRX GoodRx Holdings	Feb 27, 2025	BUY	Buy +240.6% avg upside 28 analysts	$6.00 63.11% Upside	-62.5%	·
HCAT Health Catalyst	Feb 26, 2025	HOLD	Buy +224.1% avg upside 15 analysts	$6.00 246.88% Upside	-64.6%	·
AGL Agilon Health	Feb 25, 2025	BUY	Buy -31.4% avg upside 26 analysts	$3.50 96.42% Downside	-86.2%	·
OPRX OptimizeRx	Jan 08, 2025	HOLD	Strong Buy +82.2% avg upside 9 analysts	$6.00 15.35% Downside	+146.9%	·
MDRX Veradigm	Mar 13, 2024	BUY	Buy +200.7% avg upside 22 analysts	$11.00 124.50% Upside	-36.0%	·
OTRKQ Ontrak	May 11, 2022	HOLD	Hold +2171666566.7% avg upside 7 analysts	$2.00 199999900.05% Upside	·	·
NUVB Nuvation Bio	Nov 10, 2021	BUY	Strong Buy +103.6% avg upside 15 analysts	$16.00 142.33% Upside	-77.3%	·
ACH Accendra Health	Feb 20, 2019	HOLD	Hold +820.4% avg upside 17 analysts	$7.00 150.03% Upside	+9.4%	·
IBM International Business Machines	May 19, 2017	SELL	Buy -4.2% avg upside 42 analysts	$135.00 43.12% Downside	+1.2%	·
MCK McKesson	Aug 02, 2010	BUY	Strong Buy -13.6% avg upside 28 analysts	—	+23.9%	·

🔒 25 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Sean Dodge — Frequently Asked Questions

How accurate are Sean Dodge's stock ratings?

Based on the calls 13Foresight could measure, about 65% of Sean's ratings were profitable over a one-year hold, with an average return of +6.3% per rating, or +0.9% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.

How is Sean ranked on 13Foresight?

Sean Dodge is currently ranked #1139 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Sean cover?

Sean most recently has ratings on PRVA, OMDA, DOCS, EVH, LFST, SHC, MDLN, ADUS, CERT, BTSG, IQV, WAY and 18 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Sean Dodge

Rating Distribution

Welcome to 13Foresight!